Page tree

Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.
Comment: SB 07/02/2025: Addition of AOB section (Briefing Note and April Meetings)

...

Item

Description

Mins

Owner

Notes & Actions

1Welcome and introductions2

Recording, notes & attendance.


2Ways of working, new chairs2

Frequency of meetings, alternate timezones

Meeting notes:


3EDQM Map Update5

Plan for 2025 EDQM Map update

Meeting notes:


4DCAP Update5
  • Update - Achievements and current status.

Meeting notes:


5Coordinated substances submissions15
  • New policy for accepting substances.
  • Identify authoritative sources and processes. Role of EMA as a source.
    • Requirement of agreements?
  • Streamline donations from extensions (based on DCAP experience)
  • Distributed authoring. Role of members authors in creating content.

Meeting notes:


6Current status of the Drug Model and proposals for modifications25
  • Summary of proposals for improvements to the drug model
  • Listen to member's feedback and prioritization
  • Goal:
    • Formulate requirements for the international edition.

Meeting notes:


7RxNorm - SNOMED Alignment5

@Rob Wynne

Nicholas McGraw 


Introduction to requirements and challenges in the US Drug Extension
8AOB

Briefing Note open for feedback

Inactivation of Active Duplicate Descriptions in the Same Hierarchy

  • Relevant to Drug Modelling: basic dose form, unit of presentation, intended site, state of matter, administration method, qualifier value
  • Link to Briefing Note on Confluence HERE
  • Feedback by 31st March 2025 to Maria Braithwaite via info@snomed.org


Reminder: April Business Meetings - Oslo

  • Info and Registration for in person attendance HERE
  • DEUSG Meeting Scheduled for Wed 9th April 1.30pm (local time)